Chief Operating Officer

Managing a small team, the Chief Operating Officer is a new role that has been created to strengthen the Finance department and play a pivotal role in ensuring Finance, Governance, HR, Legal, IT are responsive and efficient.,

• Developing a trusted and effective relationship with the CEO to lead the organisation collaboratively
• Oversee all aspects of finance including delivering the financial strategy, overseeing financial planning, control and reporting
• Monitor and assess the financial impact of any strategic initiatives or material capital projects
• Develop, direct and oversee all business activities of the charity across Operations and IT with a focus on designing systems and processes to enable efficiency and growth
• Managing IT systems and security in partnership with our outsourced IT provider
• Develop and oversee an effective HR function to ensure there are appropriate HR processes and procedures in place in collaboration with our outsourced HR partner, Please note we're not responsible for the content of job ads, as they're posted by the recruiter. We'll aim to resolve the reported issue and we'll use your feedback to improve the quality of our ads.
  
  In order to be successful in the role, we are looking for a formally qualified senior finance leader who will have gained their relevant financial management experience within a charity/not-for-profit organisation.
You will have an in-depth understanding of the complexities of restricted/unrestricted funds from a variety of revenue streams. With excellent communication skills you will confidently build relationships with the CEO and budget holders, becoming the trusted advisor to the Board of Trustees and senior leadership team. Experience gained in a multi-faceted leadership role is preferred but consideration will be given to candidates wishing to step up into a role that is wider than finance alone.

'Ataxia' is an umbrella term for a group of neurological disorders that affect balance, coordination and speech. A serious but rare condition thought to affect 12,000 adults and around 500 children in the UK. We provide advocacy and support those affected. We are actively involved as the patient voice for the first USA approved drug for the condition.